AN2 Therapeutics, Inc. (ANTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.97
Day's range
$6.91

AN2 Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIVO CAPITAL, LLC 08/14/2026 3.15 M $15.26 M   0.00% 7.05%
COMMODORE CAPITAL LP 08/14/2026 2.93 M $14.20 M   25.71% 6.55%
MILLENNIUM MANAGEMENT LLC 08/14/2026 2.32 M $11.22 M   4.33% 5.18%
BLACKROCK, INC. 08/07/2026 1.67 M $8.06 M   422.48% 3.72%
SPRUCE STREET CAPITAL LP 08/13/2026 1.66 M $8.04 M   0.00% 3.71%
ALMITAS CAPITAL LLC 08/17/2026 1.47 M $7.11 M   -0.68% 3.28%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.24 M $6.00 M   22.51% 2.77%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 1.00 M $4.84 M   0.00% 2.23%
CITADEL ADVISORS LLC 09/02/2026 952.00 K $4.61 M   513.25% 2.13%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 749.04 K $3.63 M   0.00% 1.67%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 697.81 K $3.38 M   143.52% 1.56%
SUMMITTX CAPITAL, L.P. 08/14/2026 597.45 K $2.89 M   100.00% 1.33%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 556.03 K $2.69 M   100.00% 1.24%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 551.69 K $2.67 M   -22.72% 1.23%
AMERIPRISE FINANCIAL INC 08/14/2026 537.06 K $2.60 M   -22.86% 1.20%
SIO CAPITAL MANAGEMENT, LLC 08/14/2026 529.93 K $2.56 M   -19.37% 1.18%
ALLY BRIDGE GROUP (NY) LLC 08/14/2026 526.32 K $2.55 M   0.00% 1.18%
PROSIGHT MANAGEMENT, LP 08/14/2026 474.64 K $2.30 M   -7.97% 1.06%
WOODLINE PARTNERS LP 08/14/2026 459.81 K $2.23 M   -53.73% 1.03%
STATE STREET CORP 09/22/2026 311.60 K $1.51 M   170.48% 0.70%
NORTHERN TRUST CORP 08/13/2026 214.92 K $1.04 M   397.55% 0.48%
SEVEN FLEET CAPITAL MANAGEMENT LP 08/17/2026 208.95 K $1.01 M   4.63% 0.47%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 196.92 K $953.09 K   43.00% 0.44%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 179.59 K $869.24 K   100.00% 0.40%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 08/12/2026 167.45 K $810.44 K   -43.84% 0.37%
BANK OF AMERICA CORP /DE/ 08/14/2026 145.80 K $705.69 K   -62.97% 0.33%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 129.70 K $627.75 K   -34.76% 0.29%
GOLDMAN SACHS GROUP INC 08/14/2026 87.93 K $425.60 K   100.00% 0.20%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 76.05 K $368.06 K   100.00% 0.17%
UBS GROUP AG 08/13/2026 74.09 K $358.58 K   20.68% 0.17%
WALLEYE CAPITAL LLC 08/03/2026 72.14 K $349.15 K   100.00% 0.16%
BANK OF NEW YORK MELLON CORP 08/06/2026 67.68 K $327.55 K   100.00% 0.15%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 64.22 K $310.83 K   100.00% 0.14%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 64.22 K $310.83 K   100.00% 0.14%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 59.90 K $289.92 K   0.00% 0.13%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 58.81 K $284.63 K   324.27% 0.13%
MORGAN STANLEY 08/13/2026 49.38 K $239.00 K   -78.91% 0.11%
CAPTRUST FINANCIAL ADVISORS 08/13/2026 40.17 K $194.40 K   0.41% 0.09%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 08/14/2026 40.00 K $193.60 K   100.00% 0.09%
NUVEEN, LLC 08/11/2026 35.33 K $171.01 K   100.00% 0.08%
DEUTSCHE BANK AG\ 08/07/2026 25.84 K $125.06 K   100.00% 0.06%
RHUMBLINE ADVISERS 08/12/2026 24.34 K $117.81 K   100.00% 0.05%
WELLS FARGO & COMPANY/MN 08/14/2026 22.39 K $108.36 K   100.00% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 22.02 K $107.00 K   100.00% 0.05%
TWO SIGMA INVESTMENTS, LP 08/14/2026 15.91 K $77.02 K   100.00% 0.04%
INVESCO LTD. 08/14/2026 13.84 K $66.98 K   100.00% 0.03%
LPL FINANCIAL LLC 08/07/2026 12.35 K $59.77 K   100.00% 0.03%
CITIGROUP INC 08/03/2026 12.27 K $59.37 K   -35.73% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 08/14/2026 12.19 K $58.98 K   100.00% 0.03%
JPMORGAN CHASE & CO 08/12/2026 10.97 K $55.18 K   100.00% 0.02%

AN2 Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 87 institutional investors and hedge funds held shares of AN2 Therapeutics Inc. The most heavily invested institutionals were:

Vivo Capital, LLC: 3.15 M

COMMODORE CAPITAL LP: 2.93 M

MILLENNIUM MANAGEMENT LLC: 2.32 M

BlackRock, Inc.: 1.67 M

Spruce Street Capital LP: 1.66 M

Almitas Capital LLC: 1.47 M

55.07% of AN2 Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 26.33 M shares in the last 24 months. This purchase volume represents approximately $138.21 M in transactions.